Company Filing History:
Years Active: 2007-2022
Title: Akifumi Hagi: Innovator in Anti-Inflammatory Solutions
Introduction
Akifumi Hagi is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing innovative anti-inflammatory agents. With a total of 6 patents to his name, Hagi's work has the potential to impact various medical treatments.
Latest Patents
One of Hagi's latest patents is a method of treating and/or preventing inflammation by administering olanexidine. The objective of this invention is to provide a composition that can be used as a novel anti-inflammatory agent. This composition can ameliorate and/or prevent inflammation related to conditions such as stomatitis, oral mucositis, gingivitis, or pneumonia. The formulation preferably includes a poloxamer, which is a block copolymer consisting of a chain of polyoxypropylene and two chains of polyoxyethylene flanking the polyoxypropylene.
Another significant patent is for a skin disinfectant composition. This invention aims to provide a disinfectant liquid that allows for easy identification of application sites during preoperative skin disinfection. The liquid is created by coloring an aqueous solution of olanexidine gluconate, which is otherwise colorless and transparent. The disinfectant liquid comprises olanexidine gluconate, a coloring agent such as Sunset Yellow FCF, and an alkyl dimethylamine oxide, among other components.
Career Highlights
Hagi has worked with prominent companies in the pharmaceutical industry, including Otsuka Pharmaceutical Factory, Inc. and Otsuka Pharmaceutical Company, Limited. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.
Collaborations
Hagi has collaborated with notable colleagues such as Kazuyoshi Miyata and Yasuhide Inoue. Their combined efforts have likely enhanced the quality and impact of their research and inventions.
Conclusion
Akifumi Hagi is a distinguished inventor whose work in anti-inflammatory solutions showcases his commitment to advancing medical science. His innovative patents and collaborations reflect his significant contributions to the pharmaceutical field.